Wavefront technology approval
This article was originally published in The Gray Sheet
Shipments of Zywave II and Orbscann IIz eye diagnostic systems begin immediately upon PMA supplemental approval of the Zypotix personalised LASIK system, announced Oct. 10, building on Bausch & Lomb's Technolas 217z excimer laser platform. B&L will launch a series of TV ads for the system, approved to treat myopia up to -7 diopters and astigmatism up to -3 D (1"The Gray Sheet" Sept. 15, 2003, p. 9). Competitors include Visx and Alcon...
You may also be interested in...
Bausch & Lomb will launch a TV ad campaign for the Zyoptix custom wavefront ablation system upon FDA approval by year-end, Senior VP and CFO Stephen McCluski said at the Bear Stearns annual healthcare conference in New York Sept. 9
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.